Ultragenyx sets $3.95 million price for rare disease gene therapy
Ultragenyx sets $3.95 million price for rare disease gene therapy
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Ultragenyx sets $3.95 million price for rare disease gene therapy
Clean Harbors prices $600 million senior notes offering
Reddit CEO Steve Huffman sells $2.77m in shares after option exercise
CoTec closes $12.1M convertible debenture financing
Indie Semiconductor CEO sells $155,460 of Class A shares
Perdoceo Education president & CEO Todd Nelson sells $1.52m in shares
The SEC is giving tokenized stocks a regulated U.S. pathway, while keeping trading volumes, access and issuer rights tightly controlled.
The SEC is giving tokenized stocks a regulated U.S. pathway, while keeping trading volumes, access and issuer rights tightly controlled.
Centuri Holdings at Morgan Stanley conference: growth plan takes shape
Tigress Financial raises Alphabet stock price target on AI growth
Nathaniel Lipman, Dave & Buster’s director, buys $81,300 in stock
US FCC approves foreign investment in Paramount Warner merger deal
PepsiCo elects Joaquin Duato to board of directors, effective December 1
PepsiCo elects Joaquin Duato to board of directors, effective December 1
Mexico stocks higher at close of trade; S&P/BMV IPC up 0.58%
Mexico stocks higher at close of trade; S&P/BMV IPC up 0.58%
The estranged daughter of 77-year-old Kathleen Allman has petitioned a Hawaiian court to establish a limited conservatorship to protect her parents’ share of her brother’s stake in Ondo.
The estranged daughter of 77-year-old Kathleen Allman has petitioned a Hawaiian court to establish a limited conservatorship to protect her parents’ share of her brother’s stake in Ondo.
DevvStream shareholders approve merger and move to Delaware at special meeting
DevvStream shareholders approve merger and move to Delaware at special meeting
News text belongs to its source; only the headline and a short summary appear here.